Axinn Represents Thermo Fisher in $1.3B Acquisition of Affymetrix
January 11, 2016
Axinn is representing Thermo Fisher Scientific Inc. in its $1.3 billion acquisition of Affymetrix, a leading provider of cellular and genetic analysis products. The Axinn team consists of John Harkrider, Mark Alexander and Kail Jethmalani.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Consero Healthcare General Counsel Forum 2026
Sponsorship
Antitrust
Energizing Tomorrow: The Future of Energy, Antitrust & International Business Law
Sponsorship
Antitrust
IBA Annual Conference 2026
Sponsorship
Antitrust
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
The DOJ’s Antitrust Whistleblower Rewards Program
Webinar
Antitrust
Axinn Secures Win for Google in Ad Tech Case
Deals & Cases
Antitrust

